Medy Tox Financials
| 086900 Stock | KRW 132,600 6,700 5.32% |
Medy |
Understanding current and past Medy Tox Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Medy Tox's financial statements are interrelated, with each one affecting the others. For example, an increase in Medy Tox's assets may result in an increase in income on the income statement.
Please note, the presentation of Medy Tox's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Medy Tox's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Medy Tox's management manipulating its earnings.
Medy Tox Stock Summary
Medy Tox competes with Hugel. Medy-Tox Inc., a biopharmaceutical company, develops, manufactures, markets, and sells botulinum toxin and hyaluronic acid dermal filler products primarily in South Korea. Medy-Tox Inc. was founded in 2000 and is headquartered in Cheongju, South Korea. MedyTox is traded on Korean Securities Dealers Automated Quotations in South Korea.| Instrument | Korea Stock View All |
| Exchange | KOSDAQ |
| ISIN | KR7086900008 |
| Business Address | 78, Gak-ri 1-gi, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.medy-tox.co.kr |
| Phone | 82 4 3217 1555 |
| Currency | KRW - South Korean Won |
You should never invest in Medy Tox without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Medy Stock, because this is throwing your money away. Analyzing the key information contained in Medy Tox's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Medy Tox Key Financial Ratios
Medy Tox's financial ratios allow both analysts and investors to convert raw data from Medy Tox's financial statements into concise, actionable information that can be used to evaluate the performance of Medy Tox over time and compare it to other companies across industries.| Return On Equity | 0.053 | |||
| Return On Asset | 0.0304 | |||
| Target Price | 156381.0 | |||
| Number Of Employees | 577 | |||
| Beta | 0.76 |
Medy Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medy Tox's current stock value. Our valuation model uses many indicators to compare Medy Tox value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medy Tox competition to find correlations between indicators driving Medy Tox's intrinsic value. More Info.Medy Tox is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers reporting about 0.57 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Medy Tox is roughly 1.74 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Medy Tox by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Medy Tox's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Medy Tox Systematic Risk
Medy Tox's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Medy Tox volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Medy Tox correlated with the market. If Beta is less than 0 Medy Tox generally moves in the opposite direction as compared to the market. If Medy Tox Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Medy Tox is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Medy Tox is generally in the same direction as the market. If Beta > 1 Medy Tox moves generally in the same direction as, but more than the movement of the benchmark.
Medy Tox February 27, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Medy Tox help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Medy Tox. We use our internally-developed statistical techniques to arrive at the intrinsic value of Medy Tox based on widely used predictive technical indicators. In general, we focus on analyzing Medy Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Medy Tox's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.85 | |||
| Information Ratio | 0.0491 | |||
| Maximum Drawdown | 24.81 | |||
| Value At Risk | (4.08) | |||
| Potential Upside | 4.68 |
Complementary Tools for Medy Stock analysis
When running Medy Tox's price analysis, check to measure Medy Tox's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medy Tox is operating at the current time. Most of Medy Tox's value examination focuses on studying past and present price action to predict the probability of Medy Tox's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medy Tox's price. Additionally, you may evaluate how the addition of Medy Tox to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |